The Cell Lysis and Disruption market is anticipated to reach USD 4454.01 Million by 2030 at 8.90% CAGR during the forecast period 2022-2030
Cell Lysis and Disruption Market Synopsis
Cell lysis & disruption is a method in which the cell membrane is broken down in order to extract the nucleic acids or proteins from a cell. The choice of cell lysis method depends on the type of cells, concentration, application (post-processing) and efficiency required. The demand for cell lysis & disruption is increasing due to the rising number of research & development activities in the biotechnology industry. This is majorly attributed to the increasing adoption of biotech processes in the pharmaceutical, agricultural sector.
Cell Lysis and Disruption Market Influencer
The expansion of the biopharmaceutical sector and growing advancements in personalized medicine is positively influencing the cell lysis and disruption market. Moreover, the rising demand for novel therapeutics and the increasing prevalence of diseases is responsible for positive cell lysis and disruption market growth.
By Cell Type
|Market Size||2030: USD 4454.01 Million|
|Forecast Units||Value (USD Billion)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Technique, Product, Cell Type, End-User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Thermo Fisher Scientific, Inc. (US), Merck KGAA (Germany), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Becton Dickinson & Company (US), Cell Signaling Technology, Inc. (US), Miltenyi Biotec (Germany), Hoffmann–La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Qsonica, LLC (US)|
|Key Market Opportunities||New product launches and R&D Amongst major key Players|
|Key Market Drivers||
Cell lysis disruption market is expected to be valued at USD 4454.01 Million by 2030.
The Cell lysis disruption market is expected to exhibit a strong 8.90% CAGR over the forecast period from 2022 to 2030.
Rising R&D activities in the biotechnology industry are the major driver for the cell lysis disruption market.
The Americas are the leading regional market due to the presence of a strong biotech industry in the region.
Leading players in the market include Merck, Danaher, and Becton Dickinson and Company, among others.